[Conduction disorders induced by piperazine; clinical and experimental study].
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D001919:Bradycardia; D002037:Bundle-Branch Block / Q000139:chemically induced*; D002543:Cerebral Hemorrhage; D002986:Clinical Trials as Topic; D003326:Coronary Circulation / Q000187:drug effects; D003937:Diagnosis, Differential; D004562:Electrocardiography; D006326:Heart Auscultation; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007362:Intensive Care Units; D008297:Male; D008991:Monitoring, Physiologic; D010138:Pacemaker, Artificial; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011346:Prochlorperazine / Q000494:pharmacology; D012075:Remission, Spontaneous; D012151:Resuscitation; D013575:Syncope
D014150:Antipsychotic Agents; D010879:Piperazines; D007099:Imipramine; D011346:Prochlorperazine
Les troubles de conduction induits par la pipérazine; étude clinique et expérimentale.